CNS & Neurological Disorders - Drug Targets
Title:Conference Report: Nanotechnology Congress & Expo 2015, Frankfurt, Germany August 11-13, 2015
Volume: 14 Issue: 9
Author(s): Hari Shanker Sharma and Aruna Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Sharma Shanker Hari and Sharma Aruna, Conference Report: Nanotechnology Congress & Expo 2015, Frankfurt, Germany August 11-13, 2015, CNS & Neurological Disorders - Drug Targets 2015; 14 (9) . https://dx.doi.org/10.2174/187152731409151127173235
DOI https://dx.doi.org/10.2174/187152731409151127173235 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Magnetic Resonance-Based Metabolomics for Understanding Neurological Disorders: Current Status and Statistical Considerations
Current Metabolomics Origins, Controversies and Recent Developments of the MCI Construct
Current Alzheimer Research Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Treatment of Periodontitis for the Prevention of Endothelial Dysfunction: A Narrative Review
Current Vascular Pharmacology Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
Current Pharmaceutical Design Heme Oxygenase -1 Gene Therapy: Recent Advances and Therapeutic Applications
Current Gene Therapy UGT1A1 Mediated Drug Interactions and its Clinical Relevance
Current Drug Metabolism Anesthetic Considerations for Electroconvulsive Therapy-Especially Hemodynamic and Respiratory Management
Current Psychiatry Reviews Current Therapeutic Options for Alzheimers Disease
Current Genomics Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy Impaired Cerebral Autoregulation and Vasomotor Reactivity in Sporadic Alzheimer’s Disease
Current Alzheimer Research Secondary Hypertension: The Ways of Management
Current Vascular Pharmacology The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Models of Infection Before and After Stroke: Investigating New Targets
Infectious Disorders - Drug Targets